Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker.
Wijbrandts
Carla A
CA
Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Vergunst
Clarissa E
CE
Haringman
Jasper J
JJ
Gerlag
Danielle M
DM
Smeets
Tom J M
TJ
Tak
Paul P
PP
D000906:Antibodies / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology* / Q000628:therapy*; D015415:Biomarkers; D001706:Biopsy; D018932:Chemokine CCL2 / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D008264:Macrophages / Q000473:pathology*; D008565:Membrane Proteins / Q000276:immunology; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000276:immunology; D013583:Synovial Membrane / Q000276:immunology / Q000473:pathology*
D000906:Antibodies; D015415:Biomarkers; C488033:C5AR1 protein, human; C111835:CCL2 protein, human; D018932:Chemokine CCL2; D008565:Membrane Proteins; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement